Comparison

SARS-CoV NCAP (HLA-A*02:01) European Partner

€184.00
Excl. VAT
Item no. EP14603_5
Manufacturer peptides & elephants
Amount 5 mg
Category
Type Peptides
Applications FC
Specific against SARS-CoV-2
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias RLNQLESKM Nucleoprotein HLA-A*02:01 Coronavirus(COVID-19) Flow Cytometry
Available
Description
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane glycoprotein (M), hemagglutinin-esterease dimer (HE), envelope protein (E), nucleocapsid protein (N), spike protein (S) and others. The nucleocapsid protein has different functions in the coronavirus replication cycle. SARS-CoV Nucleocapsid A2 316-324 (HLA-A*02:01) is a linear peptidic epitope studied as part of nucleoprotein from severe acute respiratory syndrome-related coronavirus.
Keywords
RLNQLESKM Nucleoprotein HLA-A*02:01 Coronavirus(COVID-19) Flow Cytometry
Sequence
RLNQLESKM
N-Terminus
H
C-Terminus
OH
Purity
0, 95
Counter-Ion
TFA
Protein
Nucleoprotein
Gene
N
Allele
HLA-A*02:01
Application
Flow Cytometry
Indication
Coronavirus(COVID-19)
Storage
Store dry at -20°C

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
Listprice: €184.00
Price: €184.00
available

Delivery expected until 9/18/2025 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close